About
Theragen Bio

Global genome service provider and
AI-based biopharmaceutical company

Learn more
SCROLL

Newsroom

Find out the latest news about Theargen Bio

PR
Theragen Bio Strengthens Global Leadership with the Inauguration of Baek Soon-myung as New CEO

2024-04-01

Theragen Bio Strengthens Global Leadership with the Inauguration of Baek Soon-myung as New CEO
PR
Theragen Bio, published in the international Article ‘Scientific Reports’ DEEPOMICS® FFPE paper approved for publication

2024-02-01

Theragen Bio, published in the international Article ‘Scientific Reports’ DEEPOMICS® FFPE paper approved for publication
PR
Signed a contract with Theragen Bio Arontier to jointly develop an AI-based personalized cancer vaccine design platform

2024-01-17

Signed a contract with Theragen Bio Arontier to jointly develop an AI-based personalized cancer vaccine design platform
PR
[Press Release]Theragen Bio Achieves 1000th Run with Illumina's 'NovaSeq 6000' S4

2023-12-08

[Press Release]Theragen Bio Achieves 1000th Run with Illumina's 'NovaSeq 6000' S4
PR
[News1]Theragen Bio Donates Genetic Analyzer to Korea Biomeister High School

2023-12-07

[News1]Theragen Bio Donates Genetic Analyzer to Korea Biomeister High School
PR
[Press Release]Theragen Bio registers a patent for the AI platform DEEPOMICS® NEO for neoantigen vaccine design.

2023-12-06

[Press Release]Theragen Bio registers a patent for the AI platform DEEPOMICS® NEO for neoantigen vaccine design.
PR
[Yonhap News]Developed ‘liver cancer early diagnosis marker’ with blood resources provided by the Human Resources Bank

2023-11-23

[Yonhap News]Developed ‘liver cancer early diagnosis marker’ with blood resources provided by the Human Resources Bank
PR
[Good Morning Economy] [2023 Seoul Success Grand Prize] ‘Genome analysis company’ Theragen Bio, Pharmaceutical Bio Grand Prize

2023-11-22

[Good Morning Economy] [2023 Seoul Success Grand Prize] ‘Genome analysis company’ Theragen Bio, Pharmaceutical Bio Grand Prize
PR
[Press Release]Theragen, Element Bioscience Introduce AVITI for the First Time in South Korea

2023-10-13

[Press Release]Theragen, Element Bioscience Introduce AVITI for the First Time in South Korea
PR
[NASDAQ]Agilent (A) Boosts Genomic Profiling With New Collaboration

2023-09-25

[NASDAQ]Agilent (A) Boosts Genomic Profiling With New Collaboration
PR
[Press Release]Theragen Bio to Strengthen R&D and Advance Digital Healthcare Services through Theragen Health Spin-off

2023-09-12

[Press Release]Theragen Bio to Strengthen R&D and Advance Digital Healthcare Services through Theragen Health Spin-off
PR
[Press Release]Theragen Bio and Korea University Ansan Hospital sign MOU to produce and analyze precision genomic data

2023-07-10

[Press Release]Theragen Bio and Korea University Ansan Hospital sign MOU to produce and analyze precision genomic data
PR
[Press Release]Theragen Bio renews international ISO 27001 and 27701 for 4 years in succession

2023-07-04

[Press Release]Theragen Bio renews international ISO 27001 and 27701 for 4 years in succession

PR
[Press Release]Theragen Bio has obtained a patent for an NGS-based COVID-19 diagnostic and variant determination system for the advancement of infectious disease diagnosis.

2023-05-23

[Press Release]Theragen Bio has obtained a patent for an NGS-based COVID-19 diagnostic and variant determination system for the advancement of infectious disease diagnosis.
PR
[Press Release]Theragen Bio and Agilent Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

2023-04-26

[Press Release]Theragen Bio and Agilent Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

PR
[Press Release]Theragen Bio and KAD sign MOU for building a domestic sewer-based monitoring System

2023-04-25

[Press Release]Theragen Bio and KAD sign MOU for building a domestic sewer-based monitoring System
PR
[Press Release]Theragen Bio acquires patent for predicting primary sites of cancer of unknown primary using genomic data.

2023-03-21

[Press Release]Theragen Bio acquires patent for predicting primary sites of cancer of unknown primary using genomic data.
PR
[Press Release]Theragen Bio, registered 8 patents related to genomics analysis and published 21 papers.

2022-12-22

[Press Release]Theragen Bio, registered 8 patents related to genomics analysis and published 21 papers.
PR
[Press Release]Theragen Bio donates cosmetics worth KRW 125 million to underprivileged groups for year-end charity

2022-12-08

[Press Release]Theragen Bio donates cosmetics worth KRW 125 million to underprivileged groups for year-end charity
PR
[Press Release]Theragen Bio and Herbalife Korea launch jointly developed genetic analysis service Gene Start+

2022-08-08

[Press Release]Theragen Bio and Herbalife Korea launch jointly developed genetic analysis service Gene Start+
Close